The Prostate

Journal

Publication Venue For

  • Genetic polymorphisms at 19q13.33 are associated with [−2]proPSA (p2PSA) levels and provide additional predictive value to prostate health index for prostate cancer.  81:971-982. 2021
  • CXCL12γ induces human prostate and mammary gland development.  80:1145-1156. 2020
  • A CD24-p53 axis contributes to African American prostate cancer disparities.  80:609-618. 2020
  • Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancer.  79:1629-1639. 2019
  • Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer.  79:1715-1727. 2019
  • Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancer.  Epub ahead of print. 2019
  • Wnt receptor Frizzled 8 is a target of ERG in prostate cancer.  78:1311-1320. 2018
  • Epigenetic risk score improves prostate cancer risk assessment.  77:1259-1264. 2017
  • Expression and Role of PAICS, a De Novo Purine Biosynthetic Gene in Prostate Cancer.  77:10-21. 2017
  • Prostate cancer-derived cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages.  76:624-636. 2016
  • PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.  75:1610-1619. 2015
  • A comprehensive resequence-analysis of 250 kb region of 8q24.21 in men of African ancestry.  74:579-589. 2014
  • Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network.  74:61-69. 2014
  • Canine prostate cancer cell line (Probasco) produces osteoblastic metastases in vivo.  74:1251-1265. 2014
  • Pharmacokinetics and toxicology of a fibroblast activation protein (FAP)-Activated prodrug in murine xenograft models of human cancer.  74:1308-1319. 2014
  • Prostate cancer patients older than 70 years treated by radical prostatectomy have higher biochemical recurrence rate than their matched younger counterpart.  73:897-903. 2013
  • Intraductal carcinoma of the prostate: Precursor or aggressive phenotype of prostate cancer?.  73:442-448. 2013
  • Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer models.  72:1542-1549. 2012
  • Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: Implications for focal therapy.  72:1179-1186. 2012
  • Anti-tumor effects of endogenous prostate cancer-specific CD8 T cells in a murine TCR transgenic model.  72:514-522. 2012
  • LL-37 as a therapeutic target for late stage prostate cancer.  71:659-670. 2011
  • TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients.  71:489-497. 2011
  • Effect of intermittent fasting with or without caloric restriction on prostate cancer growth and survival in SCID mice.  70:1037-1043. 2010
  • Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.  70:817-824. 2010
  • Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats.  69:1668-1682. 2009
  • Tumoristatic effects of endostatin in prostate cancer is dependent on androgen receptor status.  69:1055-1066. 2009
  • Virtual in vivo biopsy map of early prostate neoplasm in TRAMP mice by MRI.  69:449-458. 2009
  • Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen.  69:159-167. 2009
  • Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.  69:1-11. 2009
  • Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues.  68:766-772. 2008
  • Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis.  68:11-19. 2008
  • Epigallocatechin-3-gallate suppresses early stage, but not late stage prostate cancer inTRAMP mice: Mechanisms of action.  67:1576-1589. 2007
  • Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro.  67:774-781. 2007
  • Discrimination between benign and malignant prostate tissue using chromatin texture analysis in 3-D by confocal laser scanning microscopy.  67:248-254. 2007
  • Expression and activation of αvβ3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells.  67:61-73. 2007
  • Prostate cancer cells regulate growth and differentiation of bone marrow endothelial cells through TGFβ and its receptor, TGFβRII.  66:632-650. 2006
  • Effect of docetaxel chemotherapy on the activity of a gonadotropin releasing hormone vaccine in patients with advanced prostate cancer.  65:316-321. 2005
  • Bi-directional interactions of prostate cancer cells and bone marrow endothelial cells in three-dimensional culture.  64:75-82. 2005
  • Transgenic mouse with human mutant p53 expression in the prostate epithelium.  61:26-34. 2004
  • Osteopontin stimulates a subpopulation of quiescent human prostate epithelial cells with high proliferative potential to divide in vitro.  35:83-94. 1998
  • Evaluation of adjuvant estramustine phosphate, cyclophosphamide, and observation only for node-positive patients following radical prostatectomy and definitive irradiation.  28:51-57. 1996
  • Accumulation of the p53 protein occurs more frequently in metastatic than in localized prostatic adenocarcinomas.  25:243-248. 1994
  • Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation.  22:335-345. 1993
  • Metabolic action of prolactin in regressing prostate: Independent of androgen action.  6:49-59. 1985
  • Action of prolactin in regressing prostate: Independent of action mediated by androgen receptors.  5:589-595. 1984
  • Prognostic significance of tumor grade and stage in the patient with carcinoma of the prostate.  4:13-31. 1983
  • International Standard Serial Number (issn)

  • 0270-4137
  • Electronic International Standard Serial Number (eissn)

  • 1097-0045